You got that right Scooter. Some investors are blind to the deception that was common place for years.

Hey the meeting happened five years ago and NP blew it up.

Nader will never work in Biotech space again.

Getting rid of him is a prerequisite to any chance of BP considering any type of relationship with CYDY. Understand about 5 years ago Gilead was strongly considering getting in bed with CYDY. NP blew that deal up w the initial meeting by being the arrogant jerk that he is.

Nader’s mismanagement of CYDY for so many years is a travesty.

No question Kobe. Many got lucky w the Covid Cash Cow. If not for the Covid Opportunity the SP would have never risen much above a buck.

Absolutely. Many me first moves. As one CYDY Exec told me a long time ago, “Nader is a greedy guy that tells SH’s what they want to hear”.

The level of deception that Nader continued to dish out year after year is what made me pull the trigger during the Covid opportunity. I just asked myself how I could remain invested for the long term w a CEO I didn’t believe or trust?

IMO the sinking SP represents the markets assessment of the valuation of the 200M shares that will supply the oxygen to keep CYDY breathing.

What can these 200M shares fetch? It’s going to be a gut punch because it’s going to have to be very enticing. Can investors be lured into a private raise at .40 SP matched w 1.5 warrants? That would translate into $32M in gross proceeds if that were to be applied to all 200M shares.

The point is with a $10M monthly burn and approximately one months cash on hand its time to get real about finding a real partner w bank before the company goes BK. Something is better than nothing and beggars can’t be choosers.

Nader has always overvalued LL. The long time loyal Long’s love his stance because it makes them feel like they are going to make a fortune. Unfortunately Nader’s ignorance and inability to gain clarity has left CYDY boxed in a corner with very few options and a clock that is ticking at the tune of $333k per day.

With all the bridges Nader has burned within the biotech fraternity it’s going to most likely be a fire sale.

The SP is back to pre Covid valuation. Covid was the cash cow and Nader temporarily capitalized with what he does best - smoke and mirrors.

That play has run its course and Nader has made a mess of the HIV opportunity. Now the reality of the value of 200m additional shares is sinking in.

The last raise I participated in was .40 shares w warrants. Looks like that deal is going to be available once again. For all you believers that will be your opportunity to roll the dice and a shot at the lottery. I don’t have the balls or belief to do that again.

But hey you never know, maybe lightening can strike twice in CYDY land.

I pray you are right. There is value in LL. Completing a successful trial and navigating the FDA process has been the hurdle.

Don’t take it personal Rabbit. Your opinion is just as valid as any. My opinion is simply that. Holds no more weight than anybody else’s. I have pondered reinvesting many times.

The reason I have not was shared in my opinion. I’m not here to rain on any ones parade or dream for that matter. Just adding my perspective.

The fact is this is a very risky play that has huge upside potential ROI - as it should. No secrets here. Investor gets what he sign up for w CYDY. Boom or bust.

It takes bank to do that. The pipeline is tightening up and only going to get more expensive.

The most concerning question I would have as a SH for 2022 is how is NP going to continue raising $ to keep the boat afloat.

This is NP’s strong suit - raising $. He has always been able to put together some type of deal to entice investors. The head wind is obvious. As authorized shares continue to increases the pressure on the SP increases and the investment becomes less attractive from a valuation perspective. It will become increasingly taxing on the CYDY balance sheet to raise money because the raises or going to be a gut punch.

Bottom line is what is the salvage value of the molecule if CYDY becomes insolvent and is forced to close up shop. That’s what SH’s are going to divi up if the bottom falls out.

The company can always cut expenses back to a trickle but that will cut the advancement of the molecule to a snails pace.

If one looks at the progression of Pro-140 to LL to present the barrier has always been the lack of resources and skill to expedite trials and navigate the FDA process. How in the world is LL going to make it across the finish line on a tightening budget with NP at the controls. I think that formula has been proven to be futile.

The market is saying the same thing with the SP sinking below $1.

Thx Luv. I made a few bucks but nothing to gloat about as I didn’t bail anywhere near the $10 high. I truly wish all Longs here the best as I understand and have experienced the disappointments of this investment.

The molecule has a place somewhere in the Cancer and HIV space and perhaps w Covid severe. It’s not a level playing field and that makes it all the more difficult. Hopefully one day LL will get approved.

I remember when authorized shares were increased from 100m to 200m. That pissed me off because it cut the value of the CYDY investment in half. Conversely the potential of Pro 140 at the time seemed to warrant the needed capital to reach a development level to entice a BP partner or possible buyer. SH’s were always told we were so close.

That was just the beginning of the continual diluting coupled with increasingly toxic raises as the share count will soon reach 1B with no BP partnership or suitor in sight.

Amazingly enough the Covid outbreak created an opportunity and Nader took full advantage with the weekly paid for Proactive Investor interviews with Christine Corrado. It was all she could do to keep a straight face as she would gather herself to conduct the contrived interview. Nonetheless Nader created a way out of what had been a complete debacle with the HIV play into the biggest story on the planet - Covid19. That was the window that many Longs had dreamed of when the SP was stuck below 50 cents and quickly blasted to $10 for a moment. That gift horse has since ridden off into the sunset.

Loyal longs have been led down the Nader road of deception. As I reflect on all of the promises he has made it makes me wonder if he is delusional, dishonest, or just a calculating shark - probably all of the above. He drinks his own cool-aid and then is able to repackage and sell the new flavor over and over again. I was one of those that liked the taste of the cool-aid enough to participate in three private raises.

Maybe a Netflix series is a possibility with all of the ups and downs and drama that has unfolded over the last decade with Cytodyn. Nader is obnoxiously entertaining and resilient. Just need a talented writer to write the screen play. That might be the best option at this point to make some real bank on this beleaguered investment.

But hey what do I know. The SP might be headed to double or even triple digits in 2022. Fact is nobody can predict the future although we all bet that we can.

Merry Christmas and Happy New Year to all of CYDY die hard Longs. May your ship come in.

Its a tough game w many moving parts.

I exited long ago during the Covid run up - not at the $10 top but in the $5’s. I made a nice return after building a sizable position through the private raises and converting cheap warrants. I earned every penny riding that rollercoaster.

God forbid maybe I’ll take another shot but my gut says stay away.

I looked around the corner for over eight years. Always so much hope and promise. Nader is like an old Oak Tree. A permanent fixture that will not be uprooted and will likely never give up trying to gain FDA approval for LL. I give him credit for his tenacity and self preservation but that’s about it.

Good luck to the many long term SH’s you may very well see this ship come in someday. I just wasn’t willing to tie up my capital and mental energy indefinitely.

A saga that is much more pleasing to watch from the sidelines. Nader’s continuous subterfuge is nauseating.

When Nader split the sheets w Patterson it was another example of Nader’s inability to recognize the importance of assembling a team and sharing the stage. Nader manages in the same way Tiger Woods manages his team. If you start to overshadow your fired. Difference is Nader is not Tiger Woods.

He has a perception that he’s the smartest guy in the room all of the time. The tragedy is his insecurity and need to protect his power has cost SH’s what should have been a successful drug approval and buy out years ago.

That wasn’t an apology. Rabbit has been here a very long time. I know the peeps here as well as any. On the payroll - not.

When I sold the stock it went back up to high 6’s two months later. I didn’t look smart then.

It could still do it again. Tricky to liquidate. I hope you and others get the opportunity. NP was my reason for getting out. Very disappointed - should have been a $15/$10B buy out pre Covid.

No disrespect Rabbit.

Sorry you took it that way Rabbit.

Anyone that is unable to see through the Nader dance by now is delusional. The cycle of events surrounding NP’s tenure have been repeating for nearly a decade. He is consistent and predictable.

The Covid play is all but dead and the HIV play has been totally mismanaged. Only hope for SH’s is to replace Nader and salvage what can be salvaged with an upside down balance sheet that is headed further South.

BP clearly wants nothing to do with NP despite LL’s promise. They know they can sit and wait and pick up LL at scrap value after Nader finishes running this company completely into the ground.

Nader had his day in the sun as he capitalized on the Covid hype with his own brand of hype running the stock up to $10 for a millisecond. That was a gift horse that vanished quickly. I wasn’t quick enough to pull the trigger anywhere near the peak but I did manage to get out at $5. That eight year run of promises and hope I experienced was consistently met with disappointment like clockwork with deception as the common denominator.

If your on this merry go round it will be the best day of your life when you finally get off provided the bag your holding isn’t too heavy.

Hopefully I’m wrong on my opinion and all of the loyal longs will get another shot to liquidate - albeit a moon shot at this point.

It appears that NP will take the LL ship down come hell or high water. It’s a shame this game changer molecule could not escape his incompetence.

I’ll give NP credit he’s driven and relentless.

For all the loyal longs I hope he pulls yet another rabbit from the hat. He’s already done it once by raising the SP to a high of $10 w the Covid opportunity.

The question is how much runway does he have left.

Spot on - you nailed it.

Musical chairs. The only chair that needs to be pulled is the CEO chair. It’s hard to fathom how NP gets away w his shenanigans year after year. The king of the next indication that is going to monetize LL at an astronomical level.

Whatever ever happened to just simply completing the HIV BLA Combo? Nope that’s way out of his league. Starting a new trial sounds like the solution. I hate to point out the obvious but how can anybody believe in this cyclical dance that repeats itself like a broken record.

I’m looking for a reason to invest but this is ridiculous. Replace him and the stock probably doubles.

You nailed it Breeze. The Nader dance is one of constantly selling the future and how excited he is. Excitement for the future has not moved the chains. Some investors see right through his deception. Others have to experience the dance many times before the light comes on. I was a slow learner.

Bottom line is he better get an approval or an EUA somewhere in the near term because the company is running on fumes. Without some type of revenue generator in the Covid space this is going to be a very rough road from a financial perspective. The company simply lacks the resources to move all of the trials forward w any kind of speed - and they are small trials.

NP would be wise to increase the size of the For Sale sign and reduce the asking price to attract BP. That is the pathway for LL to finally make it through the approval process. The question is can NP get out of the way?

There are many savvy investors that agree — NP has to go.

Oh, if it was only that easy as to convince the BOD to vote him out. The reality is some pretty heavy hitters have given it their best shot and struck out. Mark my words NP will not go down w/o taking the CYDY w him. He’s a fixture folks — it’s like taking out a 100 year old Oak tree w all of its roots— you have to be prepared to take out so much more than the visible tree one can see above ground. NP disposes of anyone that is a potential threat to his domain. He’s really good at having his own back.

You are a pillar Misiu. A woman of principle and class. I know your going to your grave w LL. Hope you get the holy grail.

You are a man of discipline that sticks to your plan. Man if I’d had the balls to swing trade this I’d have made a fortune. Appreciate your charts and respectful demeanor Dolphin.

Best of luck to you.

You are shrewd and wise 3X. I have always valued your opinion as they cut to the chase. GLTU.

And that is what I would do if I were you. Just don’t be afraid to take some profits on the next move up.

Thank you wordman.

Confusing and poorly PR’s are one of many very frustrating business practices that continues to occur like clockwork under NP’s watch.

Unfortunately that is just one of many. I stayed invested for just over seven years and liquidated last summer in the midst of the Covid cash cow that flipped the SP out of the penny stock abyss. Didn’t cash out anywhere near the top but got out at an average of a shade under $5. One can never sell at the top or buy at the low although I managed to convert a handsome amount with the tender offer years prior at an average of .266. I had to twist my wife’s arm to exercise and take advantage as she thought I was throwing more $ at a belly up penny stock.

I always believed in the science but grew increasingly weary of NP and his deceptive over promise and never deliver merry go round. I can’t tell you how grateful I was for Covid saving this cratering investment. I always knew the S/C Covid trial was where the best short term chance was/is for LL. I came very close to jumping back in for a chunk on the pull backs but I just couldn’t pull the trigger because of the thought of my hard earned cash resting on NP’s shoulders. Seven plus years of my life was enough. A good friend that has remained invested w millions of shares said why would you put yourself through that pain again. That hit home.

So many here will say if your out why come back and post. I’ll tell you why. I invested a ton of time and psychological capital posting on this board. I’m not here to tell anybody how smart I am or that I knew the trial was going to hit a speed bump - because nobody did. Bottom line is I feel the pain of the loyal long term CYDY investors at this disappointing juncture. Been there and played that hand more times than I should have. I truly hope this works out and you are rewarded w a much larger payday than I - you will have earned every penny.

GLTA my fellow investors that are honest straight up people.

Saltz

If they fired both of them I would get back in.

IMHO Nader would have been well served to not do the CC today. The meat was the update in enrollment of the CD 12 trial.

Wait one week and PR the trial has been fully enrolled. That’s news and sets up the timeline. Everything else today is about how excited the company is about the abundance of indications. The BLA and Nasdaq update was a bust.

CD12 is happening and something to be excited about. Let the data do the talking. Nader had to inflate again stating that should have something 15 days after full enrollment when the trial calls for 42 days on drug.

Nader needs to stick to the meat and the facts — they are good enough.

So the Nader dance continues like a merry go round fueled by fluff and a new indication to add as the flavor of the month. A miracle molecule that has been managed w a reckless shotgun approach.

Can Nader finish and complete anything of value? That’s what SH’s have been waiting for - some longer, and some much longer than others.

Im not sure the SP can sink low enough to make this a logical play w Nader at the helm. A new CEO w Street Cred is long overdue. Either Nader gets the S/C Covid approval and or HIV BLA completed and accepted in the next few months or its back to the penny graveyard.

Meanwhile Longs are betting on Nader getting the job done because it looks like at least a 5-10 bagger minimum worst case. The reality is Nader has run the CYDY ship dry from every perspective — his track record, performance, good will, credibility, and the companies bank account leaving fewer and fewer options. The Covid fork in the road is fast approaching as the Covid gamble will be boom or bust and so will go Nader and the company.

The LL golden egg is still in tact but threatened as it has no mother goose to hatch it. Just look at the HIV Combo debacle. That was promised to have been hatched years ago.

It is what it is folks. Investing in CYDY is a binary event. If you think the S/C trial is going to get approved then load up. If you don’t well get ready to catch a falling knife.

“In NPs world this is not true. He is somewhat a politician say anything to get votes not realizing that he is hurting stockholders with his unwise talk tales”

LMAO—The Nader dance. It’s like being on a hamster wheel. The man has incredible stamina.

Good one. It remains to be seen how big that middle finger gets today.

Cowtown,

You covered the Covid dilemma as it pertains to both LL and the heroes in the trenches with such preciseness and clarity.

The trial design and statistical data needed for halting and ultimate approval is why the trial will and cannot be unblinded. If Nader had any shot he’d pull the trigger but he knows it would most likely be suicide and the end of the Covid play. Statistical relevance has to have a significant number of patients North of 300 to move the FDA. That’s the process. It is a travesty for the severely infected Covid patients and unfortunate for a small unproven biotech that lacks the resources and horsepower to expedite enrollment — that’s the FDA process as the DSMB can only make recommendations and has no power when it comes to approvals.

As for the doctors my heart goes out to the decisions you are confronted with and the needless death you are exposed to. Yes as Cowtown said you are heroes.

LL will have its day in the sun as long as Nader keeps his eye on the ball and focuses on just two goals.

Complete enrollment for S/C trial as rapidly as possible and let the data do the talking.

Complete the HIV combo BLA in the US and get LL approved.

Nothing else matters at this point. Diverting attention and resources to any other tasks is poor strategy and discipline.

We just need to complete the SC Trial and meet the primary endpoint. Nader needs to quit trying to shortcut the process and misleading SH’s into thinking we are going to get it done any other way. Being held to completing trials doesn’t mean we are getting screwed by the FDA it’s adhering to the protocol. Halting at interim or 75% enrollment would require crushing the PE because enrollment is still under the 300 patient sample the FDA looks for to support safety and efficacy.

We lack horsepower to enroll and compete. That’s the disadvantage. Time is our enemy. Hopefully working one on one w the Docs at the sites will expedite enrollment.

If Nader needs to do one thing it’s get the BLA accepted and nail down a backstop in the event Covid is a bust. That would change the risk of this investment markedly. At the moment investors are lacking confidence he can get the BLA accepted because of his track record.